d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] Daratumumab (anti-CD38) in refractory multiple myeloma, first in humans [Country] DK [Cancer type] 
Myeloma
Nordic NECT - Inclusion completed
Cancer type